Assure (IONM) Competitors

Assure (NASDAQ:IONM) and BIOLASE (NASDAQ:BIOL) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, earnings, valuation, media sentiment, profitability, analyst recommendations and dividends.

Which has more risk & volatility, IONM or BIOL?

Assure has a beta of 185.12, meaning that its share price is 18,412% more volatile than the S&P 500. Comparatively, BIOLASE has a beta of 0.67, meaning that its share price is 33% less volatile than the S&P 500.

Does the media favor IONM or BIOL?

In the previous week, Assure's average media sentiment score of 0.00 equaled BIOLASE'saverage media sentiment score.

Company	Overall Sentiment
Assure	Neutral
BIOLASE	Neutral

Do analysts recommend IONM or BIOL?

BIOLASE has a consensus price target of $0.40, indicating a potential upside of 0.00%. Given BIOLASE's stronger consensus rating and higher probable upside, analysts plainly believe BIOLASE is more favorable than Assure.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Assure	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
BIOLASE	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Is IONM or BIOL more profitable?

BIOLASE has a net margin of -41.65% compared to Assure's net margin of -25,178.32%. Assure's return on equity of 0.00% beat BIOLASE's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Assure	-25,178.32%	N/A	-249.78%
BIOLASE	-41.65%	-1,782.73%	-55.31%

Which has preferable earnings and valuation, IONM or BIOL?

BIOLASE has higher revenue and earnings than Assure.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Assure	$149K	1.01	-$26.08M	N/A	N/A
BIOLASE	$48.83M	0.00	-$20.63M	-$14.94	N/A

Do insiders and institutionals have more ownership in IONM or BIOL?

3.3% of Assure shares are held by institutional investors. Comparatively, 8.8% of BIOLASE shares are held by institutional investors. 3.8% of Assure shares are held by insiders. Comparatively, 0.3% of BIOLASE shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

BIOLASE beats Assure on 8 of the 11 factors compared between the two stocks.